z-logo
HomeZAIABlog
open-access-imgOpen Access
Besifloxacin Ophthalmic Suspension: Emerging Evidence of its Therapeutic Value in Bacterial Conjunctivitis
Author(s) -
Sarit Khimdas,
Kari L. Visscher,
Cindy Hutnik
Publication year - 2011
Publication title -
ophthalmology and eye diseases
Language(s) - English
Resource type - Journals
ISSN - 1179-1721
DOI - 10.4137/oed.s4102
Subject(s) - pharmacodynamics , medicine , antibiotics , bacterial conjunctivitis , intensive care medicine , dermatology , microbiology and biotechnology , pharmacokinetics , biology
To outline the pharmacodynamics, efficacy and safety of besifloxacin ophthalmic suspension 0.6% in the treatment of bacterial conjunctivitis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

AboutCareersPublisher PartnersContact UsGet Organisational Trial or Quote

Learn

FAQsBlogTerms of UsePrivacy Policy

Download the Zendy App

Get it on
Google Play
Download on the
App Store

Discover

Explore

Copyright Knowledge E © 2026. All Rights Reserved.